IP Library Granted Patent US 9,041,420
Granted Patent B2
US 9,041,420 · App. 13/893,142 · Granted May 26, 2015

Systems and methods for characterizing a molecule

Inventors: Roger J. A. Chen (Saratoga, CA); Randy Davis (Pleasanton, CA)
Assignee: Genia Technologies, Inc.
G01N27/447Y10T29/49117Y10T29/49002C12Q1/6816C12Q1/6869G01N2015/0038B82Y30/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,041,420
App. No.
13/893,142
Granted
May 26, 2015
Kind
B2
Abstract

Techniques for characterizing a molecule are described herein. In one example, a portion of the molecule is trapped in a nanopore, a variable voltage is applied across the nanopore until the trapped portion of molecule is moved within the nanopore, and the molecule is characterized based on the electrical stimulus required to affect movement of at least a portion of the trapped portion of the molecule within the nanopore.

Claims (27)

1. A method for nucleic acid sequencing, comprising:

(a) providing a chip comprising a membrane adjacent to an electrode;

(b) measuring a capacitance and/or resistance across said membrane; and

(c) based on said capacitance and/or resistance measured in (b), (i) applying a destruction stimulus if said membrane exhibits a capacitance less than about 5 fF/μm 2 and/or a resistance less than about 10 GΩ across said membrane under an applied voltage of about 50 mV, or (ii) forming a nanopore in said membrane if said membrane exhibits a capacitance greater than about 5 fF/μm 2 and/or a resistance greater than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

2. The method of claim 1 , wherein said destruction stimulus is applied if said membrane exhibits a capacitance less than about 5 fF/μm 2 and a resistance less than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

3. The method of claim 1 , wherein said nanopore is formed in said membrane if said membrane exhibits a capacitance greater than about 5 fF/μm 2 and a resistance greater than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

4. The method of claim 1 , further comprising forming said nanopore and directing a nucleic acid molecule to said nanopore.

5. The method of claim 1 , wherein said electrode is coupled to an integrated circuit that processes a signal detected with the aid of said electrode.

6. The method of claim 1 , wherein said membrane is in sensing proximity to an integrated circuit.

7. The method of claim 6 , wherein said integrated circuit comprises a logic controller.

8. The method of claim 1 , wherein said membrane is nanopore-less.

9. The method of claim 1 , wherein said membrane is a lipid bilayer.

10. The method of claim 1 , wherein said capacitance and/or resistance is measured using said electrode.

11. A system for nucleic acid sequencing, comprising:

(a) a chip comprising a membrane adjacent to an electrode; and

(b) a processor coupled to said chip, wherein said processor executes instructions stored on and/or provided by a memory coupled to said processor, which instructions implement a method comprising:

(1) measuring a capacitance and/or resistance across said membrane; and

(2) based on said capacitance and/or resistance measured in (1), (i) applying a destruction stimulus if said membrane exhibits a capacitance less than about 5 fF/μm 2 and/or a resistance less than about 10 GΩ across said membrane under an applied voltage of about 50 mV, or (ii) forming a nanopore in said membrane if said membrane exhibits a capacitance greater than about 5 fF/μm 2 and/or a resistance greater than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

12. The system of claim 11 , wherein said method comprises applying said destruction stimulus if said membrane exhibits a capacitance less than about 5 fF/μm 2 and a resistance less than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

13. The system of claim 11 , wherein said method comprises forming said nanopore in said membrane if said membrane exhibits a capacitance greater than about 5 fF/μm 2 and a resistance greater than about 10 GΩ across said membrane under an applied voltage of about 50 mV.

14. The system of claim 11 , wherein said method further comprises forming said nanopore and directing a nucleic acid molecule to said nanopore.

15. The system of claim 11 , wherein said electrode is coupled to an integrated circuit that processes a signal detected with the aid of said electrode.

16. The system of claim 11 , wherein said membrane is in sensing proximity to an integrated circuit.

17. The system of claim 16 , wherein said integrated circuit comprises a logic controller.

18. The system of claim 11 , wherein said membrane is nanopore-less.

19. The system of claim 11 , wherein said membrane is a lipid bilayer.

20. The system of claim 11 , wherein said capacitance and/or resistance is measured using said electrode.

Assignments (4)
MERGER Recorded Sep 22, 2023
From: GENIA TECHNOLOGIES, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 064999/0989 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; LIFE TECHNOLOGIES CORPORATION
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0170 →
RELEASE OF SECURITY INTEREST Recorded Jun 3, 2014
From: GLENVIEW CAPITAL PARTNERS, L.P.; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD; GLENVIEW CAPITAL OPPORTUNITY FUND, L.P.; GLENVIEW CAPITAL MASTER FUND, LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.
To: GENIA TECHNOLOGIES, INC
Reel/Frame 033083/0203 →
SECURITY AGREEMENT Recorded Feb 4, 2014
From: GENIA TECHNOLOGIES, INC.
To: GLENVIEW CAPITAL PARTNERS LP; GLENVIEW CAPITAL MASTER FUND LTD.; GLENVIEW INSTITUTIONAL PARTNERS, L.P.; GLENVIEW CAPITAL OPPORTUNITY FUND, LP; GLENVIEW OFFSHORE OPPORTUNITY MASTER FUND, LTD.
Reel/Frame 032161/0007 →
Continuity (3)
Continuation 13620973 · Sep 15, 2012
Continuation 12658604 · Feb 8, 2010
Related Publication 20140014513A1 · Jan 16, 2014